Skip to content
Screener

Lantheus Holdings LNTH Q2 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$388.2MBeat by $25.0M
EPS$1.55Beat by $0.25
Revenue estimate$363.2M
EPS estimate$1.30

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$360.9M
EPS estimate$1.25

Financials

Q2 2026

Income statement

See full
Revenue$388.2M+2.7%
Gross profit$241.9M+0.4%
Operating income$100.2M+13.9%
Net income$75.0M-4.7%
EPS (diluted)$1.11-0.9%

Balance sheet

See full
Cash & equivalents$595.0M-14.7%
Total debt$626.8M+1.5%
Total equity$1.3B+12.4%
Total assets$2.4B+14.1%

Cash flow

See full
Operating cash flow$92.2M+5.9%
CapEx$2.3M-70.7%
Free cash flow$89.9M+13.5%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$6.58B+89.9%
Enterprise value$6.61B+95.3%
P/E23.9×+11.6×
P/S4.2×+2.0×

Profitability

See full
Gross margin60.1%-3.6pp
Operating margin19.4%-9.4pp
Net margin17.7%-0.9pp
FCF margin24.9%-6.6pp

Returns & leverage

See full
Return on equity22.2%-3.6pp
Debt / equity0.5×-0.1×
Current ratio3.1×-1.2×

Segments

By product

See full
Oncology$240.4M—
PYLARIFY$240.4M-4.1%
Cardiology$88.3M—
Definity$88.3M+5.2%
Neuraceq$39.6M—

FAQ

When did Lantheus Holdings report Q2 2026 earnings?
Lantheus Holdings (LNTH) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Lantheus Holdings's Q2 2026 revenue and EPS?
Lantheus Holdings reported revenue of $388.2M and eps of $1.55 for Q2 2026.
Did Lantheus Holdings beat estimates in Q2 2026?
Revenue beat the consensus estimate of $363.2M by $25.0M. EPS beat the consensus estimate of $1.30 by $0.25.
How did Lantheus Holdings's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 2.7% from $378.0M a year earlier and eps declined 1.3% from $1.57.
Where can I find Lantheus Holdings's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-329622) and the 10-Q periodic report (0001193125-26-336795) directly on SEC EDGAR. The filing index links above go to sec.gov.